Androgen receptor mRNA expression in urothelial carcinoma of the bladder: a retrospective analysis of two independent cohorts

Introduction: Gender-specific differences have led to the androgen receptor (AR) being considered a possible factor in the pathophysiology of urothelial carcinoma of the bladder (UCB), but the exact role remains unclear. Materials and methods: The association of AR mRNA expression with clinicopathol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sikic, Danijel (VerfasserIn) , Erben, Philipp (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: April 2019
In: Translational oncology
Year: 2019, Jahrgang: 12, Heft: 4, Pages: 661-668
ISSN:1936-5233
DOI:10.1016/j.tranon.2019.01.005
Online-Zugang:Verlag, Volltext: https://doi.org/10.1016/j.tranon.2019.01.005
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S1936523318306478
Volltext
Verfasserangaben:Danijel Sikic, Ralph M. Wirtz, Sven Wach, Lars Dyrskjøt, Philipp Erben, Christian Bolenz, Johannes Breyer, Wolfgang Otto, Katherine A. Hoadley, Seth P. Lerner, Markus Eckstein, Arndt Hartmann and Bastian Keck

MARC

LEADER 00000caa a2200000 c 4500
001 1662780842
003 DE-627
005 20230426154239.0
007 cr uuu---uuuuu
008 190403s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.tranon.2019.01.005  |2 doi 
035 |a (DE-627)1662780842 
035 |a (DE-599)KXP1662780842 
035 |a (OCoLC)1341206625 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sikic, Danijel  |d 1982-  |e VerfasserIn  |0 (DE-588)141368551  |0 (DE-627)627282350  |0 (DE-576)323536646  |4 aut 
245 1 0 |a Androgen receptor mRNA expression in urothelial carcinoma of the bladder  |b a retrospective analysis of two independent cohorts  |c Danijel Sikic, Ralph M. Wirtz, Sven Wach, Lars Dyrskjøt, Philipp Erben, Christian Bolenz, Johannes Breyer, Wolfgang Otto, Katherine A. Hoadley, Seth P. Lerner, Markus Eckstein, Arndt Hartmann and Bastian Keck 
264 1 |c April 2019 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.04.2019 
520 |a Introduction: Gender-specific differences have led to the androgen receptor (AR) being considered a possible factor in the pathophysiology of urothelial carcinoma of the bladder (UCB), but the exact role remains unclear. Materials and methods: The association of AR mRNA expression with clinicopathological features was retrospectively analyzed in two previously described cohorts. The first cohort consisted of 41 patients with all stages of UCB treated at Aarhus University Hospital, Denmark. The second cohort consisted of 323 patients with muscle-invasive bladder cancer (MIBC) accumulated by the Cancer Genome Atlas (TCGA) Research Network. Results: AR mRNA expression is significantly higher in non-muscle-invasive bladder cancer (NMIBC) when compared to MIBC (P=.0004), with no relevant changes within the different stages of MIBC. AR mRNA expression was significantly associated with TCGA molecular subtypes (P<.0001). In the total cohort, there was no association between AR expression and gender (P=.23). When analyzed separately, females showed a significantly worse disease-free (P=.03) and overall survival (P=.02) when expressing AR mRNA above median level, while the same was not observed for men. Multivariable Cox's regression analyses revealed AR mRNA expression to be an independent prognostic marker for disease-free survival in women (P=.007). Conclusions: AR mRNA expression is significantly higher in NMIBC than in MIBC, while high AR mRNA expression is associated with worse survival in females with MIBC. Further studies need to investigate the gender-specific role of AR in UCB. 
700 1 |a Erben, Philipp  |d 1973-  |e VerfasserIn  |0 (DE-588)128501014  |0 (DE-627)373920997  |0 (DE-576)297181661  |4 aut 
773 0 8 |i Enthalten in  |t Translational oncology  |d Ann Arbor, Mich. : [Verlag nicht ermittelbar], 2008  |g 12(2019), 4, Seite 661-668  |h Online-Ressource  |w (DE-627)57436482X  |w (DE-600)2443840-6  |w (DE-576)28492945X  |x 1936-5233  |7 nnas  |a Androgen receptor mRNA expression in urothelial carcinoma of the bladder a retrospective analysis of two independent cohorts 
773 1 8 |g volume:12  |g year:2019  |g number:4  |g pages:661-668  |g extent:8  |a Androgen receptor mRNA expression in urothelial carcinoma of the bladder a retrospective analysis of two independent cohorts 
856 4 0 |u https://doi.org/10.1016/j.tranon.2019.01.005  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S1936523318306478  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190403 
993 |a Article 
994 |a 2019 
998 |g 128501014  |a Erben, Philipp  |m 128501014:Erben, Philipp  |d 60000  |d 63100  |e 60000PE128501014  |e 63100PE128501014  |k 0/60000/  |k 1/60000/63100/  |p 5 
999 |a KXP-PPN1662780842  |e 3417927625 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title":"Androgen receptor mRNA expression in urothelial carcinoma of the bladder","subtitle":"a retrospective analysis of two independent cohorts","title_sort":"Androgen receptor mRNA expression in urothelial carcinoma of the bladder"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"April 2019"}],"recId":"1662780842","relHost":[{"pubHistory":["1.2008 -"],"language":["eng"],"part":{"issue":"4","pages":"661-668","extent":"8","year":"2019","text":"12(2019), 4, Seite 661-668","volume":"12"},"title":[{"title_sort":"Translational oncology","title":"Translational oncology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"[Verlag nicht ermittelbar]","dateIssuedDisp":"2008-","dateIssuedKey":"2008","publisherPlace":"Ann Arbor, Mich."}],"recId":"57436482X","note":["Gesehen am 23.06.2025"],"id":{"eki":["57436482X"],"zdb":["2443840-6"],"issn":["1936-5233"]},"disp":"Androgen receptor mRNA expression in urothelial carcinoma of the bladder a retrospective analysis of two independent cohortsTranslational oncology","physDesc":[{"extent":"Online-Ressource"}]}],"note":["Gesehen am 03.04.2019"],"physDesc":[{"extent":"8 S."}],"id":{"eki":["1662780842"],"doi":["10.1016/j.tranon.2019.01.005"]},"name":{"displayForm":["Danijel Sikic, Ralph M. Wirtz, Sven Wach, Lars Dyrskjøt, Philipp Erben, Christian Bolenz, Johannes Breyer, Wolfgang Otto, Katherine A. Hoadley, Seth P. Lerner, Markus Eckstein, Arndt Hartmann and Bastian Keck"]},"person":[{"family":"Sikic","display":"Sikic, Danijel","role":"aut","given":"Danijel"},{"display":"Erben, Philipp","given":"Philipp","role":"aut","family":"Erben"}]} 
SRT |a SIKICDANIJANDROGENRE2019